Rising to the Occasion #3 - Using AI to Fight Medical Monopolization: Tony Wang (Ep. 109)
Tony Wang
On this podcast, we strive to connect fascinating and successful people to the next generation. But today, I’d like to change it up a bit and, in partnership with the Rise initiative, highlight some of the fascinating and successful people of my generation.
Throughout the past few weeks, I’ve been talking with winners of the Rise Challenge from various years. For the finale of this trilogy, I’ll be speaking with Tony Wang. For his Rise project, Tony developed an AI tool to address pharmaceutical monopolization.
Rise is a program that finds promising young people and provides "opportunity for life as they work to serve others." An initiative of Schmidt Futures and the Rhodes Trust, Rise is the anchor program of a $1 billion commitment from Eric and Wendy Schmidt to find and support global talent.
Topics:
How Tony tackled the monopolization of healthcare research by addressing antibiotic resistance
The process: How did you build this?
How to break down large projects into manageable pieces
What is the future of this project?
"What books have had an impact on you?"
"What advice do you have for other young people?"
Bio:
Tony Wang is a Chinese-American advocate living in the United States. Tony hopes to democratize medical research and create equality in healthcare, especially by addressing AI bias. For his Rise project, Tony developed an AI tool to address pharmaceutical monopolization, for which he was named an International Science & Engineering Fair (ISEF) Finalist. Tony hopes to create sustainable, ethical AI systems to fight for marginalized groups, especially racial minorities and the LGBTQIA+ community.